Loibl S, Loirat D, Tolaney SM, Punie K, et al. Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer. Eur J Cancer 2022;178:23-33.
PMID: 36379186